Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS
2024-519405-35-00Phase 2Authorised
- Sponsor
- MimeTech
- Start
- Jan 2025
- Modality
- Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of udonitrectag in diabetic foot ulcer (DFU), sponsored by MimeTech. Planned start Jan 2025; status: authorised.
02
Drugs
udonitrectag
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2024-519405-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519405-35-00.